No UMI (n = 177) | UMI (n = 58) | P-value | |
---|---|---|---|
Age at inclusion, years | 64.2 ± 8.8 | 66.6 ± 8.2 | 0.07 |
Women (%) | 66 (37 %) | 14 (24 %) | 0.08 |
Current smoker (%) | 16 (9 %) | 6 (10 %) | 0.80 |
Previous smoker (%) | 89 (50 %) | 32 (55 %) | 0.55 |
Family history of IHD (%) | 87 (49 %) | 30 (52 %) | 0.76 |
Hypertension (%) | 94 (53 %) | 38 (66 %) | 0.13 |
Diabetes mellitus (%) | 32 (18 %) | 17 (29 %) | 0.09 |
Previous stroke/TIA (%) | 7 (4.0 %) | 6 (10 %) | 0.09 |
PVD (%) | 6 (3.4 %) | 6 (10 %) | 0.08 |
COPD (%) | 13 (7.3 %) | 3 (5.2 %) | 0.77 |
BMI | 27.3 ± 3.5 | 27.7 ± 4.0 | 0.49 |
Waist circumference, cm | 99.1 ± 10.0 | 101.8 ± 11.7 | 0.55 |
Systolic BP, mmHg | 139 ± 17 | 143 ± 19 | 0.22 |
Diastolic BP, mmHg | 79 ± 10 | 79 ± 10 | 0.96 |
Ejection fraction, % median (IQR) | 66 (61–71) | 67 (62–72) | 0.55 |
Symptoms of angina pectoris | |||
<2 months (%) | 6 (3 %) | 1 (2 %) | 0.75 |
2-12 months (%) | 80 (45 %) | 25 (43 %) | |
>12 months (%) | 91 (51 %) | 32 (55 %) | |
Medications | |||
Aspirin (%) | 158 (89 %) | 53 (91 %) | 0.81 |
Clopidogrel (%) | 4 (2 %) | 3 (5 %) | 0.37 |
Statin/other lipid lowering agent (%) | 121 (68 %) | 46 (79 %) | 0.13 |